Mental Health

Biotech By Matthew Herper

Backed with $500 million, a startup aims to rethink psychiatric drug development

First Opinion By Anne Marie Benedicto

Covid-19 keeps delivering lessons about health care worker burnout. Will we learn them?

First Opinion By Susan Hata and Thalia Krakower

The AMA needs to declare a national mental health emergency

In the Lab By Isabella Cueto

In research first, jolts from a customized brain implant provided immediate relief to a severely depressed patient, scientists say

Health Tech By Mario Aguilar

The ‘Great Resignation’ could be health tech’s next big sales pitch

Health By Maddie Bender

Saying ‘person with schizophrenia,’ not ‘schizophrenic,’ can affect clinician beliefs, study finds

Opinions+ By Andrea Bastek

Combating the burnout bottleneck among clinical research workers

First Opinion By Ken Yeager

Covid-19 trauma complicates the 9/11 ‘anniversary effect’

Health Tech By Mario Aguilar

A startup delivers mental health care to those missed by the unicorns

First Opinion By Annette L. Stanton and Tammie Denyse

‘Reentry’ after cancer treatment offers lessons for emerging from the pandemic

Health Tech By Mario Aguilar

Mental health giants Headspace and Ginger to merge into $3 billion company

First Opinion Podcast By Patrick Skerrett

Listen: An ENT physician & an advocate on the high monetary and social costs of hearing loss

Health By Claudia López Lloreda

‘Stuck in a cul-de-sac’: Researchers are finally breaking away from the central dogma of depression

Health By Jonathan Saltzman — Boston Globe

Retired neurologist with Alzheimer’s knows firsthand the risks of Aduhelm

First Opinion By Jason Resendez and Stephanie Monroe

Clinical research doesn’t reflect the Alzheimer’s population. That needs to change

Health Tech By Mario Aguilar

Happify to release prescription app to treat depression under loosened FDA rules

First Opinion By Madhav Thambisetty

‘When Memory Fades’: Misinformation about Alzheimer’s disease and Aduhelm must be limited

Health Tech By Mario Aguilar

Therapy chatbot startup Woebot raises $90 million

First Opinion By Susan T. Mahler

Physicians, mental illness, and the problem with ‘passing’

mental health infrastructure concept illo

First Opinion By Allen Frances

Ignoring mental health infrastructure will be a costly mistake

First Opinion Podcast By Patrick Skerrett

Listen: A biostatistician on the ‘gold mine’ in our sewers

First Opinion By Emil D. Kakkis

Aduhelm’s accelerated approval offers a promising roadmap for rare neurological diseases

First Opinion Podcast By Patrick Skerrett

Listen: A sister on watching the mental health care system fail her brother

Health By Kevin Lin

How a new buddy system is helping health workers grapple with Covid’s toll

First Opinion By Ken Marek

Most Read

I fear Covid-19 is pushing young physicians out of medicine

Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder

On a limb: Despite resistance, a group of researchers is investigating the possibility of a new mental health disorder

Ketamine gives hope to patients with severe depression. But some clinics stray from the science and hype its benefits

Anxious about a big speech? This startup wants to calm you down — with a cardiac drug you pop like a mint

It’s time to recognize mental health as essential to physical health

‘What could help me to die?’ Doctors clash over euthanasia

Meghan Markle gave voice to the despair I once felt during pregnancy

All Coverage

Backed with $500 million, a startup aims to rethink psychiatric drug development

Covid-19 keeps delivering lessons about health care worker burnout. Will we learn them?

The AMA needs to declare a national mental health emergency

In research first, jolts from a customized brain implant provided immediate relief to a severely depressed patient, scientists say

The ‘Great Resignation’ could be health tech’s next big sales pitch

Saying ‘person with schizophrenia,’ not ‘schizophrenic,’ can affect clinician beliefs, study finds

Combating the burnout bottleneck among clinical research workers

Covid-19 trauma complicates the 9/11 ‘anniversary effect’

A startup delivers mental health care to those missed by the unicorns

‘Reentry’ after cancer treatment offers lessons for emerging from the pandemic

Mental health giants Headspace and Ginger to merge into $3 billion company

Listen: An ENT physician & an advocate on the high monetary and social costs of hearing loss

‘Stuck in a cul-de-sac’: Researchers are finally breaking away from the central dogma of depression

Retired neurologist with Alzheimer’s knows firsthand the risks of Aduhelm

Clinical research doesn’t reflect the Alzheimer’s population. That needs to change

Happify to release prescription app to treat depression under loosened FDA rules

‘When Memory Fades’: Misinformation about Alzheimer’s disease and Aduhelm must be limited

Therapy chatbot startup Woebot raises $90 million

Physicians, mental illness, and the problem with ‘passing’

Ignoring mental health infrastructure will be a costly mistake

Listen: A biostatistician on the ‘gold mine’ in our sewers

Aduhelm’s accelerated approval offers a promising roadmap for rare neurological diseases

Listen: A sister on watching the mental health care system fail her brother

How a new buddy system is helping health workers grapple with Covid’s toll

The approval of aducanumab isn’t the end of the story. It’s just the beginning